- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05658991
Electrophysiological Changes With Diet.
December 11, 2022 updated by: Ahmed Abdelshafy, Benha University
Retinal Functional Changes With Different Dietary Habits.
Dietary habits may affect our body by certain mechanisms, visual sense is one of the most vital human senses that needs special attention in our daily habits.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Retinal function directly related to our quality of vision, different drugs can affect our vision in certain ways, however, out unhealthy dietary habits can indirectly affect our quality of life and vision.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ahmed A Tabl, MD
- Phone Number: 01222328766
- Email: ahmad4lg@gmail.com
Study Locations
-
-
Benha
-
Banhā, Benha, Egypt, 13511
- Recruiting
- Ahmed Abdelshafy Tabl
-
Contact:
- Ahmed A Tabl
- Phone Number: 01222328766
- Email: ahmad4lg@gmail.com
-
Contact:
- Email: ahmad4lg@gmail.com
-
Principal Investigator:
- Ahmed A Tabl, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 36 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy subjects with intermittent fasting.
- obese subjects with body mass index more than 30.
Exclusion Criteria:
- patients with any retinal diseases that may ter retinal functional test.
- patients on systemic drugs that may alter retinal function.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Intermittent fasting healthy group
Healthy participants with intermittent fasting dietary habit.
|
Retinal electrophysiology to assess retinal function before and with fasting during ramadan in both groups.
|
|
Active Comparator: Obesity group
Subjects with body mass index more than 30.
|
Retinal electrophysiology to assess retinal function before and with fasting during ramadan in both groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retinal function amplitude
Time Frame: Baseline and one month after fasting in both groups.
|
Changes in amplitude of retinal electrophysiology in both groups measured in nano volt/degree.
|
Baseline and one month after fasting in both groups.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retinal function latency.
Time Frame: Baseline and one month after fasting in both groups.
|
Changes in latency of retinal electrophysiology in both groups measured in milliseconds.
|
Baseline and one month after fasting in both groups.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ahmed A Tabl, MD, Benha University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 11, 2022
Primary Completion (Anticipated)
March 30, 2023
Study Completion (Anticipated)
April 20, 2023
Study Registration Dates
First Submitted
December 11, 2022
First Submitted That Met QC Criteria
December 11, 2022
First Posted (Actual)
December 21, 2022
Study Record Updates
Last Update Posted (Actual)
December 21, 2022
Last Update Submitted That Met QC Criteria
December 11, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC-12.2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Retinal electrophysiology
-
Erasmus Medical CenterNot yet recruitingGlioma | Glioblastoma (GBM) | Brain Tumor-Glioma
-
University of MinnesotaRecruiting
-
Institut National de la Santé Et de la Recherche...Completed
-
Washington University School of MedicineRecruiting
-
Henry Ford Health SystemMedtronicCompletedAortic Stenosis | Heart Block | Aortic InsufficiencyUnited States
-
Abbott Medical DevicesEndosenseCompletedParoxysmal Atrial FibrillationCzechia, Germany
-
Rennes University HospitalCompleted
-
CathVision ApSMedicept IncCompletedCardiac ArrhythmiaUnited States
-
Washington University School of MedicineTerminated
-
Assistance Publique - Hôpitaux de ParisRecruitingAmyotrophic Lateral SclerosisFrance